University of Minnesota receives $66 million to establish new antiviral drug discovery center

The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.

Related Keywords

New York , United States , Texas , Minnesota , California , Illinois , University Of Minnesota , Baylor College Of Medicine , University Of California San Diego , Bryan Langlois , Fang Li , Reuben Harris , Emily Henderson , Uf Scripps Biomedical Research , Midwest Antiviral Drug Discovery Center , University Of Texas Health San Antonio , National Institute Of Allergy , University Of Iowa , Translational Sciences , Antiviral Program For Pandemics , University Of Mississippi , Midwest Avidd Center , Office Of Research Infrastructure Programs , Midwest Antiviral Drug Discovery Avidd Center , Georgia State University , University Of Minnesota Institute On Infectious Diseases , University Of Louisville , National Center , University Of Illinois Chicago , Biomedical Advanced Research , Nanyang Technological University Singapore , Iowa State University , Boston University , Development Authority , University Of California Berkeley , York Blood Center , University Of Minnesota Medical School , Howard Hughes Medical Institute , College Of Veterinary Medicine , University Of Arkansas , National Institute , Infectious Diseases , Midwest Antiviral Drug Discovery , Minnesota Medical , Medical School , Veterinary Medicine , Minnesota Institute , Texas Health San , Jakub Tolar , Antiviral Program , Advancing Translational Sciences , Research Infrastructure Programs , Baylor College , New York Blood Center , Biomedical Research , California Berkeley , California San Diego , Illinois Chicago , Allergy , Antiviral Drug , Covid 19 , Drug Discovery , Drugs , Medical Research , Medicine , Icrobiology , Pandemic , Public Health , Research , Cars , Ars Cov 2 ,